Etaracizumab is a humanized monoclonal IgG1 antibody that targets alpha-v beta-3 integrin. Alpha-v beta-3 integrin plays an important role in tumor angiogenesis. Etaracizumab has the potential for the treatment of cancers.
BOC Sciences specializes in small molecule synthesis, biosynthesis, purification, and characterization. It provides a wide range of research chemicals and biochemicals, including inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities and metabolites, APIs, natural compounds, ADCs, stem cell molecules and chiral compounds.